Isotechnika Pharma Inc IPHAF

RE: Chart

[labumba]

Four quarter report will come out anytime....bottom line this stock is way undervalued....lots of catch up to do pricewise if you like the 200 days average....meanwhile, whose who have confidence ain't too late to average down.....we don't see any price consolidation before hitting 50 cents....pric gap is between .25 to .75 cents...untile then you may see a double candle,  the whole perspective ls looking good...acceptence of dossiers from FDA should come out in 3 weeks and this baby is under the pennystock analysts' radar